Pancreatic cancer is one of the most aggressive tumours with the worst prognosis, partly because of the rapid emergence of resistance to treatment. But a new study from the Spanish National Cancer ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis. A new drug being ...

The SHARON trial combines chemotherapy, vitamins, and stem cells to treat advanced pancreatic cancer with BRCA or PALB2 mutations, showing promising early results. This precision medicine approach ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Scientists have created a new antibody treatment that helps the immune system recognize and attack pancreatic cancer. Pancreatic cancer cells use a sugary "disguise" to trick the immune system into ...

Chronic pancreatitis (CP) is an irreversible, inflammatory disease leading to fibrosis and both exocrine and endocrine pancreatic insufficiency. Pain is the most debilitating symptom of CP, and its ...

Early clinical and preclinical results are showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer, one of the deadliest cancers, and ...

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back. Pancreatic cancer is of particular concern. The five-year survival rate ...